Clinical Trial: Truway Whole-Body Digital Twin and Physiologic Resilience Study (TRU-OMNIBODY)

U.S., Sept. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07805044) titled 'Truway Whole-Body Digital Twin and Physiologic Resilience Study (TRU-OMNIBODY)' on Aug. 31.

Brief Summary: TRU-OMNIBODY is a prospective observational study designed to develop and independently validate a research-only whole-body digital twin. The digital twin will combine measurements from multiple body systems to create a participant-specific representation of physiologic state, resilience, and recovery.

The study plans to enroll approximately 450 adults between 18 and 80 years of age. Participants will include generally healthy adults and adults with stable cardiometabolic, respiratory, or mobility-related conditions. Study mea...